Niperotidine
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 (Z)-N1-[(2H-1,3-Benzodioxol-5-yl)methyl]-N′1-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-2-nitroethene-1,1-diamine  | |
| Identifiers | |
CAS Number  | 
|
3D model (JSmol)  | 
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.076.612 | 
| EC Number | 
  | 
| KEGG | |
| MeSH | C073716 | 
PubChem CID  | 
|
| UNII | |
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C20H26N4O5S | 
| Molar mass | 434.51 g·mol−1 | 
| Pharmacology | |
| A02BA05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Niperotidine is a histamine antagonist selective for the H2 subtype. It was studied as a treatment for excessive gastric acidity,[1] but withdrawn after human trials showed liver damage.[2]
References
- ↑ Palasciano, G; Maggi, V; Portincasa, P (1990). "The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring". The Italian Journal of Gastroenterology. 22 (5): 291–4. PMID 1983712.
 - ↑ Gasbarrini, G; Gentiloni, N; Febbraro, S; Gasbarrini, A; Di Campli, C; Cesana, M; Miglio, F; Miglioli, M; Ghinelli, F; d'Ambrosi, A; Amoroso, P; Pacini, F; Salvadori, G (1997). "Acute liver injury related to the use of niperotidine". Journal of Hepatology. 27 (3): 583–6. doi:10.1016/s0168-8278(97)80365-0. PMID 9314138.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
